The Food and Drug Administration yesterday said that products infused with CBD do not meet federal safety standards and require stricter regulations. The use of products with CBD has grown in recent years and the FDA’s announcement is likely to have a negative impact on businesses manufacturing and selling them. The FDA has asked Congress to give it the authority to oversee the burgeoning industry.
View Original Article
RetailWire is retailing’s premier online discussion forum, serving the industry as a free resource for over 18 years with compelling content that goes well beyond conventional headline reporting. Each business morning, our editors post timely topics worthy of commentary by the RetailWire BrainTrust panel of industry experts and general readership. The results are virtual round tables of industry opinion and advice covering the most dynamic trends and issues affecting the retailing industry.
https://retailwire.com/
Do you like RetailWire's articles? Follow on social!